Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supplements Spared From Melamine “Bombs” – So Far, UNPA’s Israelsen Says

This article was originally published in The Tan Sheet

Executive Summary

The dietary supplement industry has "been lucky," dodging a serious adulteration problem like the melamine contamination that has plagued pet food and infant formula businesses, Loren Israelsen says

The dietary supplement industry has "been lucky," dodging a serious adulteration problem like the melamine contamination that has plagued pet food and infant formula businesses, Loren Israelsen says.

"Bombs have been going off all around us and we've been missed so far," Israelsen, executive director of the United Natural Products Alliance, said during the group's seminar on dietary supplement good manufacturing practices Sept. 30.

Israelsen had polled conference attendees on whether they tested protein ingredients for melamine, a contaminant found in Chinese-sourced pet food, and, more recently, milk-based products such as formula. Melamine has been linked to adverse events, including death (1 'The Tan Sheet' Sept. 15, 2008, In Brief).

The overwhelming majority - more than 85 percent - of participants did not test for melamine in raw proteins. "I suggest you start doing that," Israelsen said at the conference in Salt Lake City.

Meanwhile, FDA has specified thresholds for melamine contamination. In infant formula, no level of melamine or related compounds has been found to be safe, the agency says in an interim safety and risk assessment Oct. 3. The agency is unable to establish any safe level of melamine in formula due to "gaps in our scientific knowledge about the toxicity of melamine" in infants such as consequences of formula being the sole source of nutrition for infants and the effects on premature babies with immature kidney function, FDA says.

In other food products, FDA concludes melamine levels of 2.5 parts per million and below do not raise concerns. The agency calculated this estimate based on a worst case exposure scenario in which 50 percent of the diet would be contaminated at that level.

FDA says it continues to screen products, work with foreign health agencies and governments and monitor reports from international sources to assure no melamine-tainted products enter the U.S. market.

Separately, Sen. Dick Durbin, D-Ill., and Rep. Rosa DeLauro, D-Conn., sent a letter to Commissioner Andrew von Eschenbach Sept. 29 requesting additional information on FDA's actions to protect the U.S. public from melamine contamination. The legislators requested an answer within 20 days.

- Jessica Lake ([email protected])

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102180

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel